Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Ung

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular Cancer Therapeutics|February 1, 2017
Insulin-Mediated Signaling Facilitates Resistance to PDGFR Inhibition in Proneural hPDGFB-Driven GliomasDamian A Almiron Bonnin, Cong Ran, Matthew C Havrda, et al.
Cell Cycle (Georgetown, Tex.)|January 16, 2015
Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cellsKaleigh Canfield, Jiaqi Li, Owen M Wilkins, et al.
Iscience|April 10, 2026
A multimodal atlas for immunotherapeutic targeting of AML surface heterogeneityMatthew Ung, Julia Etchin, Amanda Halfond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 InhibitionKevin Shee, Jason D Wells, Matthew Ung, et al.
Cell Reports|December 12, 2019
CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted TherapiesWilliam W Feng, Owen Wilkins, Scott Bang, et al.
Nature Communications|July 31, 2020
An integrative ENCODE resource for cancer genomicsJing Zhang, Donghoon Lee, Vineet Dhiman, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular Cancer Therapeutics|February 1, 2017
Insulin-Mediated Signaling Facilitates Resistance to PDGFR Inhibition in Proneural hPDGFB-Driven GliomasDamian A Almiron Bonnin, Cong Ran, Matthew C Havrda, et al.
Cell Cycle (Georgetown, Tex.)|January 16, 2015
Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cellsKaleigh Canfield, Jiaqi Li, Owen M Wilkins, et al.
Iscience|April 10, 2026
A multimodal atlas for immunotherapeutic targeting of AML surface heterogeneityMatthew Ung, Julia Etchin, Amanda Halfond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 InhibitionKevin Shee, Jason D Wells, Matthew Ung, et al.
Cell Reports|December 12, 2019
CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted TherapiesWilliam W Feng, Owen Wilkins, Scott Bang, et al.
Nature Communications|July 31, 2020
An integrative ENCODE resource for cancer genomicsJing Zhang, Donghoon Lee, Vineet Dhiman, et al.
Pageof 2